Center for DNA Barcoding, Department of Genetic Engineering, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603 203, India.
J Ethnopharmacol. 2020 Jun 28;256:112725. doi: 10.1016/j.jep.2020.112725. Epub 2020 Feb 29.
Ashwagandha, also known as Indian Ginseng, is a highly traded medicinal plant, which is used in Ayurveda, Siddha and Unani systems of medicine to improve cognitive function, decrease inflammation, and to counter the ill-effects of aging. Withanolide A and Withaferin A from Ashwagandha were shown to improve immunity and have anti-cancer property, respectively.
Here, we aimed to create reference DNA barcodes for W. somnifera and to authenticate root and powder samples of Ashwagandha collected from markets.
Three plant specimen of W. somnifera were collected, and reference DNA barcodes were generated using rbcL, matK, trnH-psbA, and ITS2 DNA barcode markers. Market samples in the form of root (n = 33) and powder (n = 70) were collected and authenticated using ITS2 and trnH-psbA DNA barcodes.
Genomic DNA was successfully isolated from all plant specimens and market samples. DNA barcoding showed that 77% of samples were authentic. About 22% of non-authentic samples were powder samples and only 1% were root samples. Among the non-authentic samples, 18% were completely substituted with single species (Mucuna pruriens (L.) DC., Trigonella foenum-graceum L., or Senna auriculata (L.) Roxb.) and 82% were mixed samples containing more than one species. About 63% of the mixed samples contained Ashwagandha as the major ingredient. Furthermore, we identified that six taxonomically divergent plant species from four families were present as adulterants in the mixed samples.
DNA barcoding revealed that botanical adulteration in the market samples of Ashwagandha is significant. Powder samples are more prone to adulteration than root samples. The adulterated samples contained plant material that is not related to Ashwagandha, which warrants strict quantity control and market surveillance to derive the true medicinal benefits of this medicinal plant.
Ashwagandha,也被称为印度人参,是一种高度交易的药用植物,在阿育吠陀、悉达和尤纳尼医学体系中被用于改善认知功能、减轻炎症和对抗衰老的不利影响。 Ashwagandha 中的 Withanolide A 和 Withaferin A 分别被证明具有增强免疫力和抗癌特性。
本研究旨在为 W. somnifera 创建参考 DNA 条形码,并验证从市场上采集的 Ashwagandha 根和粉末样本的真实性。
采集了三株 W. somnifera 植物标本,使用 rbcL、matK、trnH-psbA 和 ITS2 DNA 条形码标记物生成参考 DNA 条形码。采集了 33 个根样本和 70 个粉末样本的市场样本,并使用 ITS2 和 trnH-psbA DNA 条形码对其进行鉴定。
所有植物标本和市场样本均成功分离出基因组 DNA。 DNA 条形码显示,77%的样本是真实的。约 22%的非真实样本是粉末样本,只有 1%是根样本。在非真实样本中,18%完全被单一种类替代( Mucuna pruriens (L.) DC.、Trigonella foenum-graceum L. 或 Senna auriculata (L.) Roxb.),82%是含有多种物种的混合样本。约 63%的混合样本含有 Ashwagandha 作为主要成分。此外,我们发现,来自四个科的六种分类学上不同的植物物种作为掺杂物存在于混合样本中。
DNA 条形码显示, Ashwagandha 市场样本的植物掺假情况严重。粉末样本比根样本更容易掺假。掺假样本中含有与 Ashwagandha 无关的植物材料,这需要严格的数量控制和市场监测,以获得这种药用植物的真正药用功效。